Detalles de la búsqueda
1.
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96â weeks of RETROBIC Study.
J Antimicrob Chemother
; 79(3): 595-607, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267266
2.
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]).
Crit Care Med
; 49(6): e624-e633, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33861553
3.
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.
Infection
; 49(4): 677-684, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33646505
4.
A predictive model of immune recovery for DTGâ+â3TC and DTGâ+âRPV used as switching strategies in HIV+ patients.
J Antimicrob Chemother
; 77(12): 3519-3523, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36245072
5.
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV).
J Clin Med
; 12(3)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769822
6.
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV.
Viruses
; 15(4)2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37112915
7.
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic.
Viruses
; 15(2)2023 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851536
8.
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers.
Clin Microbiol Infect
; 29(1): 85-93, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940567
9.
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Medicine (Baltimore)
; 101(24): e29252, 2022 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35713430
10.
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart.
Clin Exp Med
; 21(2): 249-268, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33555436
11.
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.
Front Endocrinol (Lausanne)
; 11: 599255, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33329400
Resultados
1 -
11
de 11
1
Próxima >
>>